{
 "drug": "Cefepime Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/10/2026",
 "dayN": 196,
 "cat": "Anti-Infective",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/10/2026",
   "update_type": "New",
   "initial_posting_date": "02/10/2026",
   "package_ndc": "63323-326-20",
   "generic_name": "Cefepime Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA065441"
    ],
    "brand_name": [
     "CEFEPIME"
    ],
    "generic_name": [
     "CEFEPIME"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-326",
     "63323-340"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFEPIME HYDROCHLORIDE"
    ],
    "rxcui": [
     "1665088",
     "1665093"
    ],
    "spl_id": [
     "8c2fbf43-34bd-49d1-bda8-a2191c8bc54b"
    ],
    "spl_set_id": [
     "5e1695e0-1310-4cd8-a5da-ad1a7dcd1792"
    ],
    "package_ndc": [
     "63323-326-21",
     "63323-326-20",
     "63323-340-21",
     "63323-340-20"
    ],
    "unii": [
     "I8X1O0607P"
    ]
   },
   "update_date": "02/10/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/10/2026",
   "update_type": "New",
   "initial_posting_date": "02/10/2026",
   "package_ndc": "63323-340-20",
   "generic_name": "Cefepime Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA065441"
    ],
    "brand_name": [
     "CEFEPIME"
    ],
    "generic_name": [
     "CEFEPIME"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-340",
     "63323-326"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFEPIME HYDROCHLORIDE"
    ],
    "rxcui": [
     "1665088",
     "1665093"
    ],
    "spl_id": [
     "8c2fbf43-34bd-49d1-bda8-a2191c8bc54b"
    ],
    "spl_set_id": [
     "5e1695e0-1310-4cd8-a5da-ad1a7dcd1792"
    ],
    "package_ndc": [
     "63323-326-21",
     "63323-326-20",
     "63323-340-21",
     "63323-340-20"
    ],
    "unii": [
     "I8X1O0607P"
    ]
   },
   "update_date": "02/10/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}